Literature DB >> 19268596

Gamma knife radiosurgery for multiple brain metastases from lung cancer.

Seong-Hyun Park1, Sung-Kyoo Hwang, Dong-Hun Kang, Sun-Ho Lee, Jaechan Park, Jeong-Hyun Hwang, In-Suk Hamm, Yeun-Mook Park.   

Abstract

The aim of this study was to compare the effectiveness of gamma knife radiosurgery (GKS) for the treatment of multiple brain metastases from lung cancer with that of whole brain radiation therapy (WBRT). Patients with multiple (2-20) brain metastases were divided into two groups for initial brain tumor management: a GKS group (14 patients) and a WBRT group (19 patients). The patients were stratified by gender, age, initial Karnofsky performance status score, control of the primary site, known extracranial metastases, number of brain metastases, diameter of the maximal lesion, chemotherapy, and recursive partitioning analysis (RPA) Class. The 6-month and 1-year overall survival rates were 64.3% and 47.7%, respectively, in the GKS group, and 42.1% and 10.5%, respectively, in the WBRT group. The median survival time was 32 weeks in the GKS group and 24 weeks in the WBRT group. The overall survival time in the GKS group was significantly longer than in the WBRT group (p=0.04). The univariate analysis suggests that survival was increased in both patients with a controlled primary tumor site and in the GKS group (p=0.03, 0.04). The use of GKS in patients with multiple brain metastases significantly improved patient survival compared to the employment of WBRT. When we assessed the subgroups, systemic disease control and GKS were significant variables by univariate analysis.

Entities:  

Mesh:

Year:  2009        PMID: 19268596     DOI: 10.1016/j.jocn.2008.08.003

Source DB:  PubMed          Journal:  J Clin Neurosci        ISSN: 0967-5868            Impact factor:   1.961


  9 in total

1.  Role of stereotactic radiosurgery for multiple (>4) brain metastases.

Authors:  John H Suh; Sam T Chao; Lily Angelov; Michael A Vogelbaum; Gene H Barnett
Journal:  J Radiosurg SBRT       Date:  2011

2.  Progress in the biological understanding and management of breast cancer-associated central nervous system metastases.

Authors:  Shaheenah Dawood; Ana M Gonzalez-Angulo
Journal:  Oncologist       Date:  2013-06-05

Review 3.  Neurosurgical management of brain metastases.

Authors:  Sherise D Ferguson; Kathryn M Wagner; Sujit S Prabhu; Mary F McAleer; Ian E McCutcheon; Raymond Sawaya
Journal:  Clin Exp Metastasis       Date:  2017-09-30       Impact factor: 5.150

Review 4.  Role of stereotactic radiosurgery in patients with more than four brain metastases.

Authors:  Vikram Jairam; Veronica L S Chiang; James B Yu; Jonathan P S Knisely
Journal:  CNS Oncol       Date:  2013-03

5.  Quantifying the effects of positional uncertainties and estimating margins for Gamma-Knife® fractionated radiosurgery of large brain metastases.

Authors:  Béatrice Reiner; Peter Bownes; David L Buckley; David I Thwaites
Journal:  J Radiosurg SBRT       Date:  2017

6.  Quantifying the trigger level of the vacuum surveillance system of the Gamma-Knife eXtend™ positioning system and evaluating the potential impact on dose delivery.

Authors:  Béatrice Reiner; Peter Bownes; David L Buckley; David I Thwaites
Journal:  J Radiosurg SBRT       Date:  2016

7.  A randomised trial to compare cognitive outcome after gamma knife radiosurgery versus whole brain radiation therapy in patients with multiple brain metastases: research protocol CAR-study B.

Authors:  Wietske C M Schimmel; Eline Verhaak; Patrick E J Hanssens; Karin Gehring; Margriet M Sitskoorn
Journal:  BMC Cancer       Date:  2018-02-21       Impact factor: 4.430

Review 8.  Low-Intensity MR-Guided Focused Ultrasound Mediated Disruption of the Blood-Brain Barrier for Intracranial Metastatic Diseases.

Authors:  Ying Meng; Suganth Suppiah; Shanan Surendrakumar; Luca Bigioni; Nir Lipsman
Journal:  Front Oncol       Date:  2018-08-28       Impact factor: 6.244

9.  Single fraction stereotactic radiosurgery for multiple brain metastases.

Authors:  Dror Limon; Frances McSherry; James Herndon; John Sampson; Peter Fecci; Justus Adamson; Zhiheng Wang; Fang-Fang Yin; Scott Floyd; John Kirkpatrick; Grace J Kim
Journal:  Adv Radiat Oncol       Date:  2017-09-11
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.